PharmiWeb.com - Global Pharma News & Resources
18-Feb-2019

Vaccine Adjuvants Market Consumption Volume, Competitive Dynamics And Worldwide Overview 2028

A vaccine adjuvant enhances the ability to induce protection against infection and activates the immune systems. This response is mediated by B lymphocytes and T lymphocytes. Furthermore, vaccine adjuvant develops long term protective immunity and requires smaller amount of inactivated bacteria and virus to be used in vaccines. Adjuvant vaccines improve the efficacy of vaccines in infants, the elderly population, as the antigen delivery systems for the uptake of antigens is by the mucosa.

Increasing prevalence of infectious diseases and cancer is expected to fuel the market growth over the forecast period. Moreover, increasing number government funding for research and development and increasing number of collaborations for development and selling of adjuvants vaccine in various countries is expected to boost the vaccine adjuvants market growth over the forecast period.

An adjuvant is added to a vaccine to increase the immune response to the vaccine and helps to create a stronger immune response. The global vaccine adjuvants market report is segmented on the basis of product type, route of administration, disease type, application, and region.

Product type segment includes pathogen, adjuvant emulsion, particulate, combination, and others. Particulate segment is expected to witness rapid growth over the forecast period owing to the availability of naturally occurring pathogen.

Disease type segment includes infectious disease, cancer, and others. Cancer disease segment is expected to witness rapid growth over the forecast period owing to the increasing prevalence of cancer and increasing number of research and development activities for treatment of various type of cancer.

On the basis of application, the market is segmented based as human vaccine adjuvants and veterinary vaccine adjuvants. Human vaccine adjuvants accounts major market share owing to the increasing demand for adjuvant vaccines for treatment of disease.

Global vaccine adjuvants market segmentation, by product type:

  • Pathogen
  • Adjuvant Emulsion
  • Particulate
  • Combination
  • Others

Global vaccine adjuvants market segmentation, by route of administration:

  • Oral
  • Intradermal
  • Intranasal
  • Intramuscular
  • Others

Global vaccine adjuvants market segmentation, by disease type:

  • Infectious Disease
  • Cancer
  • Others

Global vaccine adjuvants market segmentation, by application:

  • Human Vaccine Adjuvants
  • Veterinary Vaccine Adjuvants

Get Free Sample Copy Of This Research @ https://marketresearch.biz/report/vaccine-adjuvants-market/request-sample/

Based on region, the global vaccine adjuvants are segmented into North America, Europe, Latin America, Asia Pacific and Middle East and Africa. North America contributes major market share and expected to maintain its dominance over the forecast period owing to the favourable government initiatives and well developed health care infrastructure. Asia Pacific is expected to witness rapid growth rate. This is attributed due to increasing number of contract manufacturing and research organisations in the region.

Some prominent players in the global vaccine adjuvants market are Brenntag Biosector, CSL Limited, Seppic Inc., Agenus, Inc., Novavax, Inc., SPI Pharma, Inc., Invivogen, Avanti Polar Lipids, Inc., MVP Laboratories, Inc., and OZ Biosciences.

Editor Details

Last Updated: 18-Feb-2019